Stay updated on XMT-1536 First-in-Human Study in NaPi2b-Expressing Cancers Clinical Trial

Sign up to get notified when there's something new on the XMT-1536 First-in-Human Study in NaPi2b-Expressing Cancers Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the XMT-1536 First-in-Human Study in NaPi2b-Expressing Cancers Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    Site revision updated from v3.4.1 to v3.4.2. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-13T11:52:36.000Z thumbnail image
  2. Check
    14 days ago
    Change Detected
    Summary
    Revision: v3.4.1 is now displayed, replacing the previous v3.4.0.
    Difference
    0.1%
    Check dated 2026-02-05T17:16:11.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    Added a 'Show glossary' option and updated metadata: 'Last Update Submitted that Met QC Criteria' capitalization adjusted, 'No FEAR Act Data' added, and the Revision updated to v3.4.0 (replacing v3.3.4).
    Difference
    0.2%
    Check dated 2026-01-29T06:58:42.000Z thumbnail image
  4. Check
    35 days ago
    Change Detected
    Summary
    Revision updated from v3.3.3 to v3.3.4. No study content, eligibility criteria, or results were modified.
    Difference
    0.1%
    Check dated 2026-01-15T02:45:47.000Z thumbnail image
  5. Check
    58 days ago
    Change Detected
    Summary
    Added a Locations section with Oklahoma as a trial site. This updates where the study is recruiting and participating locations are shown.
    Difference
    0.2%
    Check dated 2025-12-23T14:22:19.000Z thumbnail image
  6. Check
    86 days ago
    Change Detected
    Summary
    Revision: v3.3.2 replaces the previous v3.2.0 version.
    Difference
    0.1%
    Check dated 2025-11-24T18:06:44.000Z thumbnail image

Stay in the know with updates to XMT-1536 First-in-Human Study in NaPi2b-Expressing Cancers Clinical Trial

Enter your email address, and we'll notify you when there's something new on the XMT-1536 First-in-Human Study in NaPi2b-Expressing Cancers Clinical Trial page.